FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
    • Publication highlights
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Links
  • Events
    • Guest lectures
    • Retreats
    • Symposium
  • News
✕

A visit from Massachusetts

Augenklinik, Veranstaltung „Visiting Scientist Ksander“, v.l.: Prof. Claus Cursiefen, Dr. Maria Notara, Prof. Bruce Ksander (Schepens ERI & Harvard, Massachusetts, USA), Dr. Jacobus Bosch (Uniklinik Erlangen-Nürnberg), Prof. Ludwig Heindl

On April 26th, 2016, the DFG research unit FOR 2240 hosted Dr. Bruce Ksander (center) from Massachusetts at the Department of Ophthalmology, University of Cologne. Dr. Ksander received his Ph.D. in Immunology from the University of Illinois while studying the immune response to herpes keratitis in the laboratory of Dr. Robert Hendricks at the Illinois Eye & Ear Infirmary. His postdoctoral fellowship was with Dr. J Wayne Streilein at the University of Miami Medical School and the Bascom Palmer Eye Institute in Miami Florida where he studied the immune mechanisms that regulate ocular immune privilege to corneal allografts and intraocular tumors. He is currently an Associate Professor in the Department of Ophthalmology at Harvard Medical School and an Associate Scientist at the Schepens Eye Research Institute / Massachusetts Eye & Ear, and conducts research in three main areas: (i) understanding the function of inflammation in the Fas/FasL signaling pathway during the development of glaucoma, (ii) understanding the function of microglia and infiltrating macrophages in the development of age related macular degeneration, and (iii) restoration of the corneal epithelium using limbal stem cells. After meeting with a small group of scientists from the Dept. of Ophthalmology at the University of Cologne, including Chairman Univ.-Prof. Dr. C. Cursiefen (left), Speaker of the FOR 2240, Dr. Maria Notara (2nd from left), a scientist in the CorneaLab, affiliate of Project 1 of the FOR 2240 as well as Cologne coordinator of the EU consortium ARREST BLINDNESS, and Univ.-Prof. Dr. Ludwig Heindl (right), who together with Dr. Jacobus Bosch (2nd from right) from the University Hospital of Erlangen-Nuremberg are the principle investigators of FOR 2240 Project 4, Dr. Ksander gave a talk on the limbal stem cell gene ABCB5, claiming that normally functioning ABCB5 positive limbal stem cells are required for corneal development and repair. This gene is a new member of the ATP-binding cassette (ABC) superfamily of active transporters, and it is expressed by stem cells in both mouse and human limbus. Dr. Ksander has shown that knockout mice that lack ABCB5 did not develop a fully differentiated mature corneal epithelium.

Related posts

DOG Rokohl

DOG Rokohl

March 22, 2022

FOR 2240 Scientist Dr. Alexander C. Rokohl was awarded the Brewitt Publication Prize


Read more
RWA Schlereth 2022

Augenklinik RWA Schlereth 2022

February 18, 2022

Dr. Simona Schlereth wins RWA Science Award 2022


Read more
Yongwei Guo DOG

Yongwei Guo DOG

January 24, 2022

Dr. Yongwei Guo wins DOG Doctoral Award for outstanding dissertation


Read more

News

  • FOR 2240 scientists receive several honors at ARVO 2022
  • FOR 2240 Scientist Dr. Alexander C. Rokohl was awarded the Brewitt Publication Prize
  • Dr. Simona Schlereth wins RWA Science Award 2022
  • Dr. Yongwei Guo wins DOG Doctoral Award for outstanding dissertation
  • FOR 2240 scientist Dr. Alexander Rokohl wins DOG Science Prize “Dry Eye and Blepharitis/MGD”

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Esther Engel
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
esther.engel@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck